MIR3135B: A Potential Drug Target and Biomarker (G100616218)

MIR3135B: A Potential Drug Target and Biomarker

Molecular Intelligence (MOI) has identified a potential drug target and biomarker for the treatment of various diseases, including cancer. Specifically, MIR3135B, a nuclear transmembrane protein, has been identified as a potential drug target and biomarker for the treatment of pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer.

PDAC is a rare and aggressive form of cancer that arises from the ducts that carry bile and pancreatic enzymes from the pancreas to the small intestine. It is often treated with surgery, but post-surgery recurrence rates are high, leading to a need for more effective treatments.

MIR3135B is a protein that is expressed in high levels in the pancreas and is involved in the regulation of various cellular processes, including cell signaling, migration, and invasion. It is a potential drug target because of its involvement in these processes and its expression in the pancreas, which is the site of PDAC.

In addition to its potential as a drug target, MIR3135B has also been identified as a potential biomarker for PDAC. Its expression has been shown to be elevated in PDAC tissue compared to normal pancreatic tissue, and it has been used as a biomarker in clinical trials to monitor disease progression and response to treatment.

The identification of MIR3135B as a potential drug target and biomarker for PDAC has important implications for the development of new treatments for this aggressive and often lethal form of cancer. By targeting MIR3135B with drugs or other therapeutic agents, researchers may be able to slow down or even reverse the progression of PDAC and improve treatment outcomes for patients.

While further research is needed to fully understand the potential of MIR3135B as a drug target and biomarker for PDAC, its identification has already led to the start of clinical trials to evaluate its potential effectiveness. These studies are designed to assess the safety and effectiveness of drugs that target MIR3135B, as well as to determine its impact on the growth and survival of PDAC tumors.

In conclusion, MIR3135B is a promising drug target and biomarker for the treatment of PDAC. Its identification and potential use as a therapeutic agent for this disease represents a significant step forward in the development of new treatments for a aggressive and often lethal form of cancer. While further research is needed to fully understand its potential, the identification of MIR3135B as a potential drug target and biomarker for PDAC is a promising sign that researchers may be able to develop new treatments that will improve outcomes for patients with this disease.

Protein Name: MicroRNA 3135b

The "MIR3135B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR3135B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190 | MIR3191 | MIR3192 | MIR3193 | MIR3194 | MIR3195 | MIR3196 | MIR3197 | MIR3198-1 | MIR3199-1 | MIR3199-2 | MIR31HG | MIR32 | MIR3200 | MIR3201 | MIR3202-1 | MIR3202-2 | MIR320A | MIR320B1 | MIR320B2 | MIR320C1 | MIR320C2 | MIR320D1 | MIR320D2 | MIR320E | MIR323A | MIR323B | MIR324 | MIR325 | MIR325HG | MIR326 | MIR328 | MIR329-1